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Abstract

Introduction

Background: The worldwide prevalence of childhood obesity has
increased from 4.2% to 6.7% during the last two decades. Pediatric
obesity is a major health problem, which is dramatically increasing in
Greece. A variety of inflammatory variables have been also found to
associate with cardiometabolic (CV) risk in obese children. The purpose of this study was to identify and examine the effects of possible
CV risk factors in obese and non-obese children with and without
family history (FH) of cardiovascular disease (CVD).

The worldwide prevalence of childhood obesity has increased
from 4.2% to 6.7% during the last two decades [1]. Data from
144 countries suggest that about 43 million children are overweight and obese and 92 millions are at risk of becoming obese
later on their life [1].
Pediatric obesity is a major health problem and is dramatically increasing in Greece [2, 3]. Consequences such as
hypertension, type 2 diabetes (T2D), non-alcoholic fatty liver
disease (NAFLD), hyperlipidemia, hyperglycemia and insulin resistance (IR) are serious health issues that have been
found to be established at young ages in pediatric population
in Greece [4-6].
Cardiovascular (CV) risk in children becomes significant
from the 85th percentile for weight and above where other risk
factors changes are observed, such as high-density lipoprotein
(HDL), low-density lipoprotein (LDL), triglyceride (TG) and
total cholesterol (TC) [7]. Atherosclerosis is a process that
starts in early life as Berenson et al have reported, body mass
index (BMI), high blood pressure (BP) and high concentrations of LDL, TC and low HDL were strongly associated with
the extension of lesions in the coronary arteries [8].
A variety of inflammatory variables have been also found
to be associated with CV risk in obese children. Kim et al [9]
observed in 354 children, that the obese group had higher levels of high-sensitivity C-reactive protein (hsCRP), interleukin
and tumor necrosis factor-α compared to the non-obese ones.
IR is another well-known CV risk factor in adults and has
been proved to have a very strong association with pediatric
obesity [10]. In addition, metabolic syndrome, which is basically a cluster of CV risk factors such as hyperinsulinemia,
obesity, hypertension and hyperlipidemia, has been observed
in obese children [6].
As biomarkers of lipid metabolism, apolipoprotein A
(ApoA) and apolipoprotein B (ApoB) have been found to be
good predictors for cardiovascular disease (CVD) [11]. In addition, lipoprotein(a) (Lp(a)) which is mainly produced by
monocytes/macrophages and primarily bound to LDL cholesterol in the peripheral circulation, was found to be predictive
for CV events in adults [12].
Finally, family history (FH) is another important and independent CV risk factor, especially for early-onset disease.
Many studies have shown a two- to three-fold increase in CVD

Methods: Sixty-eight (68) healthy children and adolescents aged
7 - 13 years participated in the study. Anthropometrical and biochemical indexes were obtained from all children as well as FH
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Results: Systolic blood pressure (SBP), total cholesterol (TC), triglyceride (TG), high-sensitivity C-reactive protein (hsCRP), fasting
plasma insulin (FPI) and homeostasis model assessment of insulin
resistance (HOMA-IR) levels were found statistically significantly
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given a first-degree relative with CVD and the strength of this
association increases as the number of affected first-degree
relatives increases [13, 14].
The purpose of this study was to identify and examine the
effects of possible CV risk factors in obese and non-obese children with and without FH of CVD.

Materials and Methods
Sixty-eight (68) children and adolescents aged 7 - 13 years (35
obese and 33 controls) participated in the study. All subjects
were recruited from a pediatric obesity outpatient’s clinic and
a clinic for lipids and prevention of CVD in childhood. The
power calculation to have the appropriate number to contact
the study was 32 children. Controls were healthy children and
adolescents, with normal BMI. A detailed medical history was
taken of each child by a pediatrician of our clinic. Children
with clinical evidence of diabetes, CV, liver disease and use of
alcohol, drugs or other disease were excluded from the study.
FHs of CVD, hypertension and hyperlipidemia were also obtained from each subject. The latter was defined as positive if
there was a first-degree male relative (father or grandfather) diagnosed with CVD under the age of 55 or a first-degree female
relative (mother or grandmother) diagnosed with CVD under
the age of 65. The term CVD includes all the diseases of the
heart and circulation including coronary heart disease (angina
and heart attack), heart failure, congenital heart disease and
stroke. The Ethical Committee of the Aristotle University of
Thessaloniki approved the study and a written informed consent form was also obtained from the children’s guardians who
participated in the study.
Anthropometrical indices
Anthropometrical indices such as height, weight, Tanner
stage and waist circumference were measured in all children.
Body weight was measured to the nearest (0.1 kg) wearing
light clothes and without shoes using SECA 700 model-scale.
Height was measured to the nearest (0.1 cm) using a SECA
stadiometer. Obesity was defined by the new revised international child BMI cut-offs for sex, according to the World
Obesity Federation (previously IOTF) [15]. Blood pressure
was measured by auscultation using a mercury sphygmomanometer. The subjects were in seated position, with arm flexed
at the level of the heart. A properly sized BP cuff for children
was used to measure BP. The length of the cuff’s bladder was
at least equal to 80% of the circumference of the upper arm.
The BP was measured three times and the mean average was
considered to be the overall BP value. Normal systolic BP was
defined when percentile was < 90th percentile, pre-hypertensive when percentile ≥ 90th and < 95th and hypertensive was
defined as either systolic and/or diastolic BP ≥ 95th percentile
measured upon three or more occasions. Children and adolescents whose BP exceeded 120/80 mm Hg were considered
pre-hypertensive even if the blood pressure was < 90th percentile [16].
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Table 1. Basic Characteristics Between Boys and Girls (n =
68)
Boys (N = 28),
mean ± SD

Girls (N = 40),
mean ± SD

P-value

Age (years)

9.78 ± 3.48

9.48 ± 2.71

0.684

Height (cm)

1.41 ± 0.19

1.39 ± 0.15

0.479

Weight (kg)a

50.2 ± 26.4

43 ± 21.9

0.223

(kg/m2)a

23.67 ± 7.4

21.2 ± 6.6

0.182

SBP (mm Hg)

59.72 ± 7.8

50.3 ± 29.2

0.185

DBP (mm Hg)

57.32 ± 8.8

49.2 ± 25.4

0.224

162.4 ± 45.5

162.8 ± 29.7

0.974

78.5 ± 39.5

83.9 ± 45

0.605

48.3 ± 14.7

52.3 ± 16.8

0.307

LDL (mg/dL)

92 ± 24.1

95 ± 22.8

0.543

ApoA (mg/dL)

133.53 ± 0

140.3 ± 27.1

0.330

69.9 ± 22.2

63.6 ± 15.1

0.165

BMI

TC

(mg/dL)a

TG (mg/dL)a
HDL

(mg/dL)a

ApoB

(mg/dL)a

P < 0.05. aMann-Whitney test, all other t-test.

Biochemical indices
A blood sample of 5 mL was drawn by venipuncture after the
subjects had fasted overnight for 10 h. Fasting serum TC, HDLcholesterol and TGs were ascertained with direct measurement
assays using standard laboratory methods (Roche Diagnostics)
while LDL-cholesterol was calculated using Friedwald’s equation. hsCRP levels were determined using particle enhanced
immunoturbidimetric method. ApoA and B were measured
by the immunoturbidimetric method. Fasting blood glucose
and serum insulin levels were assessed by enzymatic method
with hexokinase and electrochemiluminescence immunoassay
“ECLIA”, respectively. IR was calculated by means of the homeostasis model assessment (HOMA) with the HOMA calculator (University of Oxford, Diabetes Trials Unit, the Oxford
Centre for Diabetes, Endocrinology and Metabolism). IR was
defined by HOMA > 2.5 IU/mL.
Statistics
The Shapiro-Wilk statistic was used to test the normality assumption of the numerical variables of the study. The main
effect of the group (normal, obese) of FH of CVD (positive,
negative) and their interaction effect were assessed with twoway ANOVA for normally distributed variables and with
Kruskal-Wallis test for non-normally distributed data. In case
of ANOVA, pairwise comparisons were conducted with Bonferroni method, while Mann-Whitney U test with Bonferroni
adjusted P-values was used for pairwise comparisons after the
Kruskal-Wallis test. Comparisons between boys and girls were
done with independent samples t-test (normally distributed
data) or with Mann-Whitney U test (non-normally distributed
data). Univariate and multivariate logistic regression models were used to associate systolic BP, TC, TG, HDL, ApoA,
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Table 2. Comparison of Normal and Obese Groups With and Without FH of CVD
Variables

Normal

Obese

PFH (n = 8)

NFH (n = 25)

Total (n = 33)

PFH (n = 15)

NFH (n = 20)

Total (n = 35)

SBP

54 ± 23.9

38.9 ± 26.6

42.5 ± 26.4

68.5 ± 24.9

63.2 ± 28.2

65.5 ± 26.6*

DBP

47.5 ± 30.1

51.2 ± 30.4

50.3 ± 29.9

53.3 ± 29.9

56 ± 19.9

54.9 ± 24.3

TC

167 ± 33

166 ± 30

167 ± 31

191 ± 18

178 ± 24

181 ± 24.5*

TG

59.5 ± 22.5

73.8 ± 42.2

70.4 ± 38.7

88 ± 44.5

95.9 ± 44.2

92.5 ± 43.8*

HDL

64.9 ± 19.3

54.4 ± 17.5

56.9 ± 18.2

41.9 ± 10

46.5 ± 10.6

44.5 ± 10.5*

LDL

88.8 ± 29.5

92 ± 43.4

90.4 ± 40.6

104.4 ± 21

99.5 ± 23

101 ± 22.9

ApoA

159.9 ± 25

141 ± 31.6

145.6 ± 31

135.4 ± 21.8**

121 ± 23.6

129 ± 23.3*

ApoB

61 ± 15.6

67.3 ± 19.3

65.9 ± 18.5

66.6 ± 22.8

66.7 ± 15.9

66.7 ± 18.9

Lp(a)a

20 (3.4 - 113.9)

21.2 (2 - 200)

21.2 (2 - 200)

16.5 (4.1 - 106)

16.5 (4.4 - 87)

16.5 (4.1 - 106)

hsCRPa

0.11 (0.01 - 2.54)

0.08 (0.01 - 2.6)

0.08 (0.01 - 2.6)

0.78 (0.03 - 2.8)

0.73 (0.02 - 2.7)

0.75 (0.02 - 2.8)*

FBG

84.4 ± 12

88 ± 7.7

87 ± 8.9

87 ± 8.7

89.5 ± 8

88.4 ± 8.4

FPIa

6.6 (1.1 - 35.6)

8.6 (2.9 - 159)

8.2 (1.1 - 159)

16 (4.5 - 42)**

11.8 (0.2 - 31)

12.8 (0.2 - 42)*

HOMA-IRb

0.95 × 2.28
(0.35 - 4.35)

1.06 × 1.68
(0.38 - 3.24)

1.03 × 1.81
(0.35 - 4.35)

1.8 × 1.9
(0.58 - 5.24)

1.43 × 1.77
(0.37 - 3.83)

1.58 × 1.83*
(0.37 - 5.24)

P < 0.05. aDistribution not normal (median, min. - max.). bData presented as log (geometric mean × geometric SD). *Statistically significant difference between obese and normal group. **Statistically significant difference between obese and normal group with PFH.

hsCRP, fasting insulin 0' and HOMA-IR with group (normal,
obese) and FH of CVD (positive, negative). Results of those
models included odds ratios (OR), 95% confidence intervals
(CIs), sensitivity and specificity. The overall analysis was performed with IBM Statistics SPSS 20.0 and the statistical significance was set at P <0.05.

Results
Out of the 68 children, 35 were obese and 33 non-obese. Fifteen (15) out of the 35 obese ones had positive FH of CVD
while eight children out of the 33 non-obese ones had positive
FH of CVD.
Table 1 represents the anthropometrical and biochemical
profile of all children based on gender. No statistically significant differences were observed between boys and girls.
SBP, TC, TG, hsCRP, fasting plasma insulin (FPI) and
HOMA-IR levels were found statistically significantly higher
in the obese group compared to the normal one. Additionally,
HDL and ApoA levels were observed to be statistically significantly lower in the obese children compared to their normal
peers. Moreover, ApoA, hsCRP and FPI levels were significantly higher in the obese children with FH of CVD compared
to those without FH of CVD (Table 2).
Figure 1 depicts the strong positive relation of FPI with
HOMA-IR (r = 0.998, P < 0.001).
In a univariate logistic regression model, none of the CV
risk factors were related to children with and without FH of
CVD (Table 3).
Table 4 represents the OR of children having obesity to
the normal ones. Obese children have almost double risk of
having high TC levels (OR: 1.965 95% CI: 1.935 - 2.970, P

< 0.031), while for the SBP the risk was OR: 1.045, 95% CI:
1.016 - 1.074, P < 0.002.

Discussion
In this study, we attempt to identify any possible relation of
CV risk factors in 68 obese and non-obese children with and
without FH of CVD.
In our study, obese children were found to have higher
risk of abnormal total fasting serum cholesterol and systolic
BP levels compared to normal children. Many authors have
evaluated the relationship of childhood obesity with BP. A European pediatric cohort showed that high BP was seen in about
35% of overweight children [17]. In another recent study [18]
that covered 26,000 school children, the systolic hypertension
observed was 5.3%, 12.3% and 14.6% for normal, overweight
and obese children, respectively. High levels of hypertension
reported in other studies from Greece should be under serious concern. Angelopoulos et al [19] examined 312 children
aged 11 years and found prevalence rates of 29.4% and 11.8%
for boys and 39% and 7.5% for girls. Additionally, others examined 606 children from Northern Greece and reported a
prevalence of systolic and diastolic hypertension of 12.3% and
15.1% for boys and 13.3% and 15.1% for girls, respectively
[20]. The probable mechanism of obesity-related hypertension
might include IR, sodium retention, increased sympathetic
nervous system activity and other factors [21].
Obesity is commonly associated with a combined dyslipidemia pattern with mild elevation in TC and LDL-cholesterol
levels, moderate-to-severe elevation in TG level, and low
HDL-cholesterol levels [22]. In our study, the obese group
presented significantly higher levels of TC, LDL and TG and
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Figure 1. Relation of HOMA with IR (r = 0.998, P < 0.001).

lower levels of HDL compared to the non-obese group. In
the multiple regression model though, only TC was independently associated with obesity. Weight loss should be the first
priority in order to reduce TC and systolic BP in obese children. A few studies on children based on short-term weight
loss over a few weeks showed an improvement of CV risk
factor profile associated with obesity (reduction of hypertension, TG, and TC) [23, 24]. Additionally, a diet with total fat
at 25-30% of calories, saturated fat at < 10% of calories, and
cholesterol intake at < 300 mg/day, as recommended by the
original NCEP Pediatric Panel [25] has been shown to safely
and effectively reduce the levels of TC and LDL-cholesterol
in healthy children.

The paradox in our study is that we did not find any relation in the logistic regression model, between HOMA and
obesity or FH of CVD. This is possibly due to the effect of the
small number of subjects included in the study. However, these
results should not underestimate the significance of HOMAIR, since IR is the main cause of hypertriglyceridemia, hyperlipidemia, decrease of HDL-cholesterol, and increased BP in
obesity, and correlates to the degree of overweight [26]. Our
study has its limitations, since information on genetics, physical activity, socioeconomic status and diet was not assessed.
Additionally, the small sample size also might affect some of
the cardiometabolic risk factors related to obese children especially those with FH of CVD.

Table 3. Univariate Logistic Regression Analysis Between Cardiometabolic Risk Factor and Family History of CVD

Table 4. Logistic Regression Analysis Between Cardiometabolic Risk Factor and Obesity

Univariate logistic regression results*
OR

95% CI

P-value

Multivariate logistic regression analysis

Sensitivity/
specificity

OR

95% CI

P-value

Sensitivity/
specificity

SBP (mm Hg)

1.018

0.999 - 1.037

0.064

0.13/0.93

SBP (mm Hg)

1.045

1.016 - 1.074

0.002*

0.13/0.93

TC (mg/dL)

1.983

1.965 - 2.001

0.070

0.13/0.96

TC (mg/dL)

1.965

1.935 - 2.970

0.031*

0.13/0.96

TG (mg/dL)

0.997

0.985 - 1.009

0.624

0.00/1.00

TG (mg/dL)

0.997

0.985 - 1.009

0.624

0.00/1.00

HDL (mg/dL)

0.996

0.965 - 1.028

0.801

0.00/1.00

HDL (mg/dL)

0.996

0.965 - 1.028

0.801

0.00/1.00

ApoA (mg/dL)

0.995

0.978 - 1.013

0.603

0.00/1.00

ApoA (mg/dL)

0.995

0.978 - 1.013

0.603

0.00/1.00

hsCRP

1.367

0.689 - 2.715

0.371

0.00/1.00

hsCRP

2.92

0.966 - 8.828

0.058

0.00/1.00

FPI (mIU/mL)

1.058

0.993 - 1.127

0.080

0.17/0.94

FPI (mIU/mL)

1.058

0.993 - 1.127

0.080

0.17/0.94

HOMA-IR

1.570

0.941 - 2.619

0.084

0.17/0.94

HOMA-IR

1.570

0.941 - 2.619

0.084

0.17/0.94

*P < 0.05.
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Conclusions
ApoA, hsCRP and FPI levels were significantly higher in the
obese children with FH of CVD compared to the ones without
FH of CVD. TC and systolic BP were found to be independently associated with obesity. In contrast, FH of CVD was
not related to any cardiometabolic risk factors. Prevention of
obesity may decrease development of CV risk.
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